Sprent J - Search Results

1

Optimising IL-2 for Cancer Immunotherapy.

Sprent J, Boyman O. Sprent J, et al. Immune Netw. 2024 Jan 26;24(1):e5. doi: 10.4110/in.2024.24.e5. eCollection 2024 Feb. Immune Netw. 2024. PMID: 38455463 Free PMC article. Review.

2

Potential use of IL-2/anti-IL-2 antibody immune complexes for the treatment of cancer and autoimmune disease.

Boyman O, Surh CD, Sprent J. Boyman O, et al. Among authors: sprent j. Expert Opin Biol Ther. 2006 Dec;6(12):1323-31. doi: 10.1517/14712598.6.12.1323. Expert Opin Biol Ther. 2006. PMID: 17223740 Review.

3

In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression.

Webster KE, Walters S, Kohler RE, Mrkvan T, Boyman O, Surh CD, Grey ST, Sprent J. Webster KE, et al. Among authors: sprent j. J Exp Med. 2009 Apr 13;206(4):751-60. doi: 10.1084/jem.20082824. Epub 2009 Mar 30. J Exp Med. 2009. PMID: 19332874 Free PMC article.

4

T cell homeostasis.

Sprent J, Cho JH, Boyman O, Surh CD. Sprent J, et al. Immunol Cell Biol. 2008 May-Jun;86(4):312-9. doi: 10.1038/icb.2008.12. Epub 2008 Mar 25. Immunol Cell Biol. 2008. PMID: 18362947 Review.

5

IL-7/anti-IL-7 mAb complexes restore T cell development and induce homeostatic T Cell expansion without lymphopenia.

Boyman O, Ramsey C, Kim DM, Sprent J, Surh CD. Boyman O, et al. Among authors: sprent j. J Immunol. 2008 Jun 1;180(11):7265-75. doi: 10.4049/jimmunol.180.11.7265. J Immunol. 2008. PMID: 18490726

6

IL-2/anti-IL-2 antibody complexes show strong biological activity by avoiding interaction with IL-2 receptor alpha subunit CD25.

Létourneau S, van Leeuwen EM, Krieg C, Martin C, Pantaleo G, Sprent J, Surh CD, Boyman O. Létourneau S, et al. Among authors: sprent j. Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):2171-6. doi: 10.1073/pnas.0909384107. Epub 2010 Jan 19. Proc Natl Acad Sci U S A. 2010. PMID: 20133862 Free PMC article.

7

The role of interleukin-2 during homeostasis and activation of the immune system.

Boyman O, Sprent J. Boyman O, et al. Among authors: sprent j. Nat Rev Immunol. 2012 Feb 17;12(3):180-90. doi: 10.1038/nri3156. Nat Rev Immunol. 2012. PMID: 22343569 Review.

8

Selectively expanding subsets of T cells in mice by injection of interleukin-2/antibody complexes: implications for transplantation tolerance.

Boyman O, Krieg C, Letourneau S, Webster K, Surh CD, Sprent J. Boyman O, et al. Among authors: sprent j. Transplant Proc. 2012 May;44(4):1032-4. doi: 10.1016/j.transproceed.2012.01.093. Transplant Proc. 2012. PMID: 22564618 Review.

9

An intense form of homeostatic proliferation of naive CD8+ cells driven by IL-2.

Cho JH, Boyman O, Kim HO, Hahm B, Rubinstein MP, Ramsey C, Kim DM, Surh CD, Sprent J. Cho JH, et al. Among authors: sprent j. J Exp Med. 2007 Aug 6;204(8):1787-801. doi: 10.1084/jem.20070740. Epub 2007 Jul 30. J Exp Med. 2007. PMID: 17664294 Free PMC article.

10

Homeostatic maintenance of T cells and natural killer cells.

Boyman O, Krieg C, Homann D, Sprent J. Boyman O, et al. Among authors: sprent j. Cell Mol Life Sci. 2012 May;69(10):1597-608. doi: 10.1007/s00018-012-0968-7. Epub 2012 Mar 30. Cell Mol Life Sci. 2012. PMID: 22460580 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

474 results

Search Page

Filters